Tsumura & Co. (TYO: 4540)

Market Cap	371.08B
Revenue (ttm)	164.61B
Net Income (ttm)	25.20B
Shares Out	75.93M
EPS (ttm)	331.92
PE Ratio	14.72
Forward PE	12.00
Dividend	136.00 (2.76%)
Ex-Dividend Date	Mar 28, 2025

Volume	234,900
Open	4,760.00
Previous Close	4,800.00
Day's Range	4,747.00 - 4,809.00
52-Week Range	2,580.00 - 5,138.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,138
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In 2023, Tsumura & Co.'s revenue was 150.85 billion, an increase of 7.71% compared to the previous year's 140.04 billion. Earnings were 16.71 billion, an increase of 1.37%.